查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1861977

血液輸注設備市場：依產品、應用、最終用戶、組件、模式、通路和技術分類－2025年至2032年全球預測

Blood Transfusion Devices Market by Product, Application, End User, Component, Mode, Distribution Channel, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，輸血設備市場規模將達到 78.3 億美元，複合年成長率為 7.46%。

關鍵市場統計數據
基準年 2024 44億美元
預計年份：2025年 47.3億美元
預測年份 2032 78.3億美元
複合年成長率 (%) 7.46%

輸血設備領域正處於臨床需求、技術創新和監管嚴格性三者交會的十字路口。設備自動化、數位化監測和材料科學的進步正在改變血液的採集、處理、儲存和輸送方式，促使臨床醫生和管理人員尋求更安全、更有效率的工作流程。本報告綜合分析了這些技術和營運趨勢，旨在為讀者清晰展現未來一段時間內將影響輸血設備應用和投資走向的動態和格局。

本分析並非僅關注產品目錄，而是著重於臨床效用、與診療路徑的整合以及對血液安全和供應鏈韌性的影響。因此，從製造商到醫院採購團隊的相關人員都能切實了解設備功能如何與臨床工作流程和監管要求相符。本引言為後續章節奠定了框架，重點闡述了決策者在評估產品系列、夥伴關係和實施策略時應考慮的關鍵轉折點和實際問題。

自動化、數位整合、病患安全優先以及採購經濟性正在同時重塑輸血設備生態系統。

四大趨勢正引領輸血醫療設備領域發生變革：自動化和精密工程、對病人安全和病原體減少的日益重視、設備數據與臨床資訊系統的數位整合，以及採購重點的轉變（強調總體擁有成本和生命週期管理）。自動化技術已從基礎機械化發展到基於複雜卡盒和盒式裝置的半自動化系統以及全機器人平台，從而實現了更一致的處理流程並減少了人為錯誤。同時，新型流量控制技術和感測器驅動的電子監測器正在提高劑量精度，最大限度地減少溶血，並實現即時干預。

此外，人們對輸血相關感染疾病的日益關注以及對成分特異性療法的需求，使得白血球去除、成分分離和病原體減少策略成為優先事項。這些臨床需求正促使製造商在過濾和離心系統方面進行創新，並開發能夠無縫整合到醫院工作流程中的床邊設備。同時，採購決策正轉向那些能夠提供互通性、遠距離診斷和可預測維護路徑的解決方案。這些變化正在推動產品改進和商業模式的革新，從而更好地滿足臨床和營運需求，並重新定義產業內的競爭優勢。

美國關稅變化促使輸血設備相關人員轉變籌資策略、轉向近岸外包並增強供應鏈韌性

美國近期關稅調整為依賴全球供應鏈獲取輸血設備和組件的製造商、經銷商和臨床終端用戶帶來了新的挑戰。關稅變化影響了進口耗材和設備的到岸成本，尤其是血袋、採血套裝以及用於血液分離和成分分離的一次性產品等大宗商品，並正在改變籌資策略。因此，各機構正在重新評估供應商多元化和國內生產的可行性，以降低關稅波動和運輸中斷帶來的風險。

為此，許多公司正在評估近岸外包和區域製造夥伴關係關係，以維持利潤率並確保及時供貨。同時，其他公司正在調整定價和合約條款，以應對關稅可能帶來的成本轉嫁。此外，血庫和醫院的採購部門也日益呼籲提高成本透明度，簽訂長期供應協議，並緊急時應對計畫，以應對關稅帶來的複雜性和合規性問題。總而言之，這些趨勢正在推動投資轉向增強供應鏈韌性，例如建立本地庫存緩衝、採用多源策略以及與物流合作夥伴更緊密地合作，以應對關稅造成的成本波動和營運風險。

全面的細分分析揭示了產品類型、臨床應用、最終用戶、組件、供應模式、分銷管道和技術如何相互作用，從而影響醫療設備的選擇。

細分市場分析揭示了臨床需求、營運限制和採購政策對輸血設備領域產品開發和商業化策略的微妙影響。就產品特性而言，產品範圍涵蓋了從複雜的血漿分離系統（單針和雙針配置）到單袋或多袋血袋。血液採集裝置設計為封閉式系統以降低污染風險，或開放式系統以適應低成本採血場景。血漿分離裝置根據通量需求提供自動和手動配置。白血球去除過濾器依臨床時間和物流需求，分為床邊型和預存型。輸液幫浦分為用於精確小劑量輸注的注射器型和用於持續輸注的容量型。這些產品層面的選擇直接影響採購規範和臨床工作流程。

基於應用領域的分類進一步明確了使用模式，涵蓋了以採集為中心的血液成分分離術（區分採集型血液成分分離術和治療型血液成分分離術）以及包括專用血液成分分離術和全血採集方法在內的血液採集工作流程。血液成分分離採用離心或過濾方法，而白血球去除可根據處理量和臨床目標採用離心或過濾機制。輸血程序本身的特徵是持續輸血與間歇性輸血，影響輸血設備的選擇和監測通訊協定。

不同的終端使用者也影響產品定位和服務模式。政府和私部門的血庫和捐血中心需要高通量、耐用且耗材供應穩定的系統，而公立和私立醫院則需要能夠融入患者照護流程並滿足不同技能等級醫護人員需求的設備。組件細分體現了血漿、血小板、紅血球和白血球不同的處理和儲存需求。血漿亞型包括冷沉澱和新鮮冷凍血漿，血小板來源包括血小板分離術和血小板池，白血球分為粒細胞濃縮液和淋巴細胞濃縮液，每種都有其獨特的處理和品管要求。

部署模式和通路的細分也會影響產品的採用模式。自動化、手動和半自動化模式（自動化產品涵蓋從全自動桌面設備到機器人系統，而半自動化設備則採用基於墨盒或盒式設計）決定了資本投入和培訓需求，而配銷通路，例如直銷、醫院藥房（集中式或院內）、透過B2B平台或製造商網站進行的在線銷售以及零售藥房，則影響著產品的可及性、摩擦和預期服務。最後，傳統流量控制方法（例如重力或壓力注射）與基於微處理器或感測器驅動的電子流量控制解決方案之間的技術選擇，在安全性、可追溯性和與臨床資訊系統的整合方面，會產生不同的價值提案。了解這些相互關聯的細分維度，有助於相關人員最佳化產品藍圖，鎖定合適的最終用戶，並設計符合臨床和營運實際情況的服務模式。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和差異化採用模式正在影響產品策略和監管方式。

區域趨勢對輸血器材領域的臨床實踐、採購行為、監管預期以及創新擴散有顯著影響。在美洲，先進的臨床基礎設施和集中的研究生態系統正在加速自動化和電子流量控制技術的應用，而集中化的報銷機制和大型醫院系統則催生了對擴充性解決方案和完善的售後支援的需求。在歐洲、中東和非洲地區，不同司法管轄區的監管一致性、醫院資金籌措機制的多樣性以及不同的捐血系統共同造就了一個異質性市場，其中既有先進器械，也有適應當地資源的器械。

在亞太地區，醫療基礎設施的快速擴張、血液服務現代化進程的推進以及強大的製造業基礎，共同推動了國內創新和出口導向生產。該地區的轉型經濟體正投資於可分階段整合的半自動化和模組化系統，而高所得市場則優先考慮完全自動化和無縫的數位化互通性。在所有地區，當地的監管差異、勞動力能力和供應鏈物流都會影響設備規格製定和臨床應用的速度。因此，製造商和經銷商必須採取針對特定地區的策略，以應對資金籌措模式、監管時間表、培訓要求和備件物流等問題，從而確保設備的持續應用和營運成功。

深入了解輸血設備市場競爭格局以及創新、夥伴關係和服務品質的策略定位，這些因素共同決定了市場領導地位。

輸血設備領域的競爭格局由產品創新、服務模式、監管專業知識和夥伴關係關係生態系統決定。主要企業透過投資自動化、基於感測器的監測和耗材設計來實現差異化，從而減少操作人員的差異並提高病患安全。同時，新興醫療技術公司和專業契約製造製造商正在推出針對價格和易用性缺口的創新產品，涵蓋從符合人體工學的血液分離模組到低成本過濾耗材等各個方面。

醫療設備製造商與臨床網路之間的策略聯盟日益普遍，從而能夠實現產品迭代檢驗、真實世界效能回饋和快速引進週期。建立完善的上市後監測、遠距離診斷和培訓專案的公司能夠加強客戶關係並降低終端用戶生命週期成本。此外，投資於可擴展的製造地和多元化分銷管道的公司能夠更好地應對力關稅波動和供應鏈中斷。最終，能夠將監管能力與模組化產品架構以及針對資源豐富和資源受限環境量身定做的服務相結合的企業將獲得競爭優勢。

針對領導者的具體建議，重點在於互通性、供應鏈韌性、提升服務品質以及圍繞臨床醫生需求設計產品。

產業領導者可以透過以下方式將洞察轉化為優勢：使產品藍圖與臨床工作流程保持一致，優先考慮互通性，並投資於供應鏈韌性。首先，醫療設備開發商應整合感測器和微處理器控制，以實現增強的安全功能和數據驅動的維護，同時確保與電子健康記錄 (EHR) 和輸血管理系統的互通性，從而簡化臨床醫生的工作流程。其次，製造商應尋求靈活的生產結構和區域夥伴關係，以降低關稅風險並縮短前置作業時間，從而實現具有競爭力的價格和可靠的服務交付。

此外，各機構應透過拓展服務提案，降低採購方的整體擁有成本，服務內容不僅限於保固和維修，還包括培訓課程、遠距離診斷和耗材管理項目。與臨床中心合作產生真實世界數據 (RWE) 有助於提高可靠性並促進報銷談判。最後，醫院和血站的採購和臨床負責人應採用多供應商合作策略和標準化規範，強調相容性、培訓支援和可預測的供應。這些措施可降低營運風險並提升長期價值實現。

一種穩健的混合調查方法，整合了監管審查、技術檢驗和臨床醫生見解，以確保設備智慧的可靠性。

調查方法結合了已發布的監管文件、技術標準和同行評審臨床文獻的系統性回顧，以及對臨床醫生、採購負責人和設備技術人員的初步定性訪談。透過對供應商文件、技術白皮書和觀察到的臨床通訊協定檢驗資料三角驗證，以確認功能聲明並識別新興的使用模式。透過對設備功能、培訓要求和上市後支援模式的交叉檢驗，應用了嚴謹的分析方法，並在評估推廣應用的促進因素和障礙時考慮了區域監管路徑。

在條件允許的情況下，我們透過多個獨立資訊來源和臨床終端使用者的觀點來驗證研究結果，以確保關於設備效用和操作適用性的論點能夠​​反映真實的臨床工作流程。調查方法的局限性包括已發表的性能數據存在差異以及部分上市後結果的保密性，但這些局限性已通過有針對性的專家諮詢得到緩解。這種混合方法提供了可操作的見解，能夠為戰略決策提供資訊，而無需依賴保密的市場規模估算或預測。

總之，我們的研究強調需要製定整合策略，將創新、臨床誠信和供應鏈遠見結合起來，以最佳化輸血實踐。

總之，輸血器材產業正日益成熟，形成一個更複雜的生態系統，器械自動化、數位化控制和供應鏈策略決定著臨床和商業性的成功。諸如白血球去除、精準的血液成分分離和安全輸血等臨床需求，正在推動產品需求和服務期望的差異化。同時，關稅波動和區域監管差異等外部壓力，迫使製造商和醫療系統在採購、本地化和全生命週期支援方面更加謹慎。

展望未來，那些將產品開發與臨床工作流程相結合、投資於互通性和感測器驅動技術、並採取穩健的生產和分銷策略的機構，將更有利於實現患者安全目標和醫療機構的採購優先事項。這一結論凸顯了整合技術創新、營運前瞻性和強力的臨床合作的策略的重要性——這對於充分發揮現代輸血設備技術的潛力至關重要。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 採用病原體減少技術提高輸血過程中的血液安全性
  • 整合智慧感測器和物聯網技術，實現血液製品在儲存和運輸過程中品質的即時監測
  • 提高自動化血型鑑定和抗體篩檢的應用率，以減少輸血錯誤
  • 開發攜帶式血液加溫/冷卻系統，用於緊急醫療護理中的快速輸血支援。
  • 床邊照護現場血液分析儀的普及，使得在床邊進行即時相容性檢測成為可能。
  • 利用人工智慧演算法預測患者輸血需求並最佳化庫存管理
  • 為最大限度降低輸血器具的污染風險，對一次性無菌輸液管和接頭的需求日益成長。
  • 穿戴式連續血紅素監測設備可實現非侵入性輸血後評估。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 輸血設備市場：依產品分類

  • 血液分離系統
    • 雙針
    • 單針
  • 輸血袋
    • 多口袋
    • 單口袋
  • 採血套裝
    • 閉型
    • 開放型
  • 組件分離裝置
    • 自動分離裝置
    • 手動分離器
  • 白血球去除過濾器
    • 床頭
    • 預儲存
  • 點滴幫浦
    • 注射器
    • 體積測量

第9章 輸血設備市場：依應用領域分類

  • 血液分離術
    • 血液採集分離術
    • 治療性血液分離術
  • 血液收集
    • 血球分離術採集
    • 全血採集
  • 組分分離
    • 離心分離法
    • 過濾法
  • 白血球去除
    • 離心分離法
    • 過濾法
  • 輸血
    • 持續輸血
    • 間歇性輸血

第10章 以最終用戶分類的輸血設備市場

  • 血庫和捐血中心
    • 政府機構
    • 私人中心
  • 醫院
    • 私立醫院
    • 公立醫院

第11章 按組件分類的輸血設備市場

  • 電漿
    • 冷沉澱物
    • 新鮮冷凍血漿
  • 血小板
    • 血小板分離術
    • 混合血小板
  • 紅血球
  • 白血球
    • 粒細胞濃縮液
    • 淋巴球濃縮物

第12章 血液輸注設備市場（依類型分類）

  • 自動化
    • 全自動桌面
    • 機器人系統
  • 手動輸入
  • 半自動
    • 墨水匣類型
    • 盒式

第13章 按通路分類的輸血設備市場

  • 直銷
  • 醫院藥房
    • 集中
    • 在醫院裡
  • 線上銷售
    • B2B平台
    • 製造商網站
  • 零售藥房

第14章 輸血設備市場：依技術分類

  • 傳統流量控制
    • 重力型
    • 壓力注射法
  • 電子流量控制
    • 基於微處理器的
    • 基於感測器的

第15章 輸血設備市場：依地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 血液輸注設備市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國輸血設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Becton, Dickinson and Company
    • Fresenius Kabi AG
    • Terumo Corporation
    • B. Braun Melsungen AG
    • Haemonetics Corporation
    • Baxter International Inc.
    • Grifols, SA
    • Macopharma SA
    • Cerus Corporation
    • Immucor, Inc.
Product Code: MRR-521BAA36EADD

The Blood Transfusion Devices Market is projected to grow by USD 7.83 billion at a CAGR of 7.46% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.40 billion
Estimated Year [2025] USD 4.73 billion
Forecast Year [2032] USD 7.83 billion
CAGR (%) 7.46%

The evolving field of blood transfusion devices is at the intersection of clinical necessity, engineering innovation, and regulatory rigor. Advances in device automation, digital monitoring, and materials science are reshaping how blood is collected, processed, stored, and delivered, while clinicians and administrators seek safer, more efficient workflows. This report synthesizes these technological and operational trends to give readers a clear orientation of the landscape and the forces that will shape adoption and investment trajectories in the near term.

Rather than focusing solely on product catalogs, the analysis emphasizes clinical utility, integration into care pathways, and the implications for blood safety and supply chain resilience. Consequently, stakeholders from manufacturers to hospital procurement teams will gain a practical understanding of how device capabilities intersect with clinical workflows and regulatory expectations. This introduction frames the subsequent sections by highlighting pivotal transitions and the practical considerations that decision-makers should weigh when evaluating product portfolios, partnerships, and deployment strategies.

How automation, digital integration, patient safety priorities, and procurement economics are simultaneously reshaping the blood transfusion device ecosystem

The blood transfusion device landscape is experiencing transformative shifts driven by four converging trends: automation and precision engineering, intensified focus on patient safety and pathogen mitigation, digital integration of device data into clinical information systems, and evolving procurement priorities that emphasize total cost of ownership and lifecycle management. Automation has progressed from basic mechanization to sophisticated cartridge- and cassette-based semi-automated systems as well as fully robotic platforms, enabling more consistent processing and reduced human error. In parallel, emerging flow control technologies and sensor-driven electronic monitors are improving dose accuracy, minimizing hemolysis, and enabling real-time intervention.

Moreover, heightened awareness of transfusion-transmitted infections and the demand for component-specific therapies have prioritized leukocyte reduction, component separation, and pathogen reduction strategies. These clinical drivers have prompted manufacturers to innovate filtration and centrifugal systems as well as bedside devices that integrate seamlessly with hospital workflows. At the same time, procurement decision-making is shifting toward solutions that offer interoperability, remote diagnostics, and predictable maintenance pathways. Taken together, these shifts are catalyzing product refinements and commercial models that better address clinical and operational imperatives, thereby redefining competitive differentiation within the sector.

Tariff changes in the United States prompting strategic shifts in sourcing, nearshoring, and supply chain resilience for blood transfusion device stakeholders

Recent tariff adjustments in the United States have introduced new complexities for manufacturers, distributors, and clinical end users that rely on global supply chains for blood transfusion devices and components. Tariff changes influence sourcing strategies by altering landed costs for imported consumables and equipment, particularly for high-volume items such as blood bags, collection sets, and disposables used in apheresis and component separation. As a result, organizations are reassessing supplier diversification and onshore manufacturing viability to mitigate exposure to tariff volatility and shipping disruptions.

In response, many firms are evaluating nearshoring and regional manufacturing partnerships to preserve margin and maintain timely supply, while others are adjusting pricing and contract terms to account for the potential pass-through of duties. Simultaneously, procurement teams within blood banks and hospitals are increasingly demanding clearer cost transparency, longer-term supply agreements, and contingency plans that address customs complexity and compliance. These reactions collectively shift investment toward supply chain resilience measures, including local inventory buffers, multi-sourcing strategies, and closer collaboration with logistics partners to manage tariff-induced cost variability and operational risk.

Comprehensive segmentation clarity revealing how product types, clinical applications, end users, components, modes, distribution channels, and technologies intersect to drive device selection

Segmentation reveals the nuanced ways clinical requirements, operational constraints, and procurement preferences shape product development and commercialization tactics within the blood transfusion device arena. When product distinctions are considered, offerings range from complex apheresis systems-available in single needle and double needle configurations-to blood bags that come as single pocket or multi pocket formats; blood collection sets are engineered as closed systems to minimize contamination risk or open systems for lower-cost collection scenarios; component separators appear as automated and manual units to serve different throughput needs; leukocyte reduction filters are positioned for bedside application or pre-storage processing to match clinical timing and logistics; and transfusion pumps are split between syringe-based devices for small-volume precision and volumetric pumps for continuous infusion demands. These product-level choices directly affect procurement specifications and clinical workflows.

Application-based segmentation further clarifies usage patterns, extending from collection-focused apheresis-distinguished between collection apheresis procedures and therapeutic apheresis interventions-to blood collection workflows that include dedicated apheresis collection and whole blood collection approaches. Component separation is executed through centrifugation-based or filtration-based methods, and leukocyte reduction can employ either centrifugation or filtration mechanisms depending on throughput and clinical objectives. Transfusion procedures themselves are characterized by continuous transfusion modalities versus intermittent transfusion episodes, impacting device selection and monitoring protocols.

End user distinctions also guide product positioning and service models, with blood banks and donation centers-operating in government-run or private configurations-demanding high-throughput, durable systems and predictable consumable supply, while hospitals, whether private or public, require devices that integrate into patient care pathways and accommodate varied staffing competencies. Component-wise segmentation recognizes the different handling and storage needs for plasma, platelets, red blood cells, and white blood cells; plasma subtypes include cryoprecipitate and fresh frozen plasma, platelets are sourced as apheresis platelets or pooled platelets, and white blood cells are categorized into granulocyte concentrates and lymphocyte concentrates, each presenting specific processing and quality control requirements.

Mode and distribution channel segmentation further influence adoption patterns; automated, manual, and semi-automated modes-where automated offerings range from fully automated desktop units to robotic systems and semi-automated devices use cartridge- or cassette-based designs-determine capital intensity and training needs, while distribution channels such as direct sales, hospital pharmacies (centralized or in-house), online sales through B2B platforms or manufacturer websites, and retail pharmacies shape accessibility, procurement friction, and service expectations. Finally, technology choices between conventional flow control methods, including gravity-fed and pressure infusion approaches, and electronic flow control solutions that are microprocessor-based or sensor-driven create distinct value propositions related to safety, traceability, and integration with clinical information systems. Understanding these interconnected segmentation axes enables stakeholders to refine product roadmaps, target the right end users, and design service models that align with clinical and operational realities.

Regional dynamics and differentiated adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping product strategies and regulatory approaches

Regional dynamics exert substantial influence on clinical practice, procurement behavior, regulatory expectations, and innovation diffusion across the blood transfusion device sector. In the Americas, advanced clinical infrastructures and concentrated research ecosystems accelerate adoption of automated and electronic flow control technologies, while concentrated reimbursement frameworks and large hospital systems create demand for scalable solutions and robust post-market support. Conversely, the Europe, Middle East & Africa region presents a heterogeneous landscape in which regulatory alignment across jurisdictions, variable hospital funding mechanisms, and differing blood donation systems lead to a mix of advanced and resource-adapted device deployments.

In Asia-Pacific, rapid healthcare infrastructure expansion, growing blood service modernization efforts, and a strong manufacturing base combine to drive both domestic innovation and export-oriented production. Transitional economies within the region are investing in semi-automated and modular systems that can be integrated incrementally, whereas high-income markets prioritize full automation and seamless digital interoperability. Across all regions, local regulatory nuances, workforce capabilities, and supply chain logistics influence device specification decisions and the pace of clinical acceptance. Consequently, manufacturers and distributors must adopt regionally tailored strategies that address funding models, regulatory timelines, training requirements, and spare parts logistics to ensure sustained adoption and operational success.

Competitive realities and strategic positioning insights that reveal how innovation, partnerships, and service excellence determine leadership in transfusion device markets

Competitive dynamics in the blood transfusion device landscape are defined by product innovation, service models, regulatory expertise, and partnership ecosystems. Leading companies tend to differentiate through investments in automation, sensor-enabled monitoring, and consumable design that reduce operator variability and improve patient safety. At the same time, emerging medtech entrants and specialized contract manufacturers are introducing niche innovations, from ergonomic apheresis modules to low-cost filtration consumables, that target gaps in affordability and usability.

Strategic partnerships between device manufacturers and clinical networks are increasingly common, enabling iterative product validation, real-world performance feedback, and faster adoption cycles. Companies that establish robust post-market surveillance, remote diagnostics, and training programs strengthen customer relationships and reduce lifecycle costs for end users. Furthermore, firms that invest in scalable manufacturing footprints and diversified distribution channels are better positioned to respond to tariff fluctuations and supply chain shocks. Ultimately, competitive advantage accrues to organizations that couple regulatory competence with modular product architectures and service offerings tailored to both high-resource and resource-constrained environments.

Actionable recommendations for leaders focusing on interoperability, supply chain resilience, service excellence, and clinician-aligned product design

Industry leaders can take concrete actions to convert insight into advantage by aligning product roadmaps with clinical workflows, prioritizing interoperability, and investing in supply chain resilience. First, device developers should embed sensors and microprocessor controls to enhance safety features and enable data-driven maintenance, while ensuring interoperability with electronic health records and transfusion management systems to streamline clinician workflows. Secondly, manufacturers should pursue flexible manufacturing and regional partnerships to reduce tariff exposure and shorten lead times, enabling competitive pricing and reliable service delivery.

Additionally, organizations should expand their service propositions beyond warranty and repair to include training curricula, remote diagnostics, and consumable management programs that lower total cost of ownership for buyers. Collaborations with clinical centers for real-world evidence generation will accelerate credibility and support reimbursement discussions. Finally, procurement and clinical leaders within hospitals and blood centers should adopt multi-vendor engagement strategies and standardized specifications that emphasize compatibility, training support, and predictable supply arrangements; these measures will mitigate operational risk and improve long-term value realization.

Robust mixed-methods research approach integrating regulatory review, technical validation, and clinician insights to ensure credible device intelligence

The research methodology combined a systematic review of publicly available regulatory documents, technical standards, and peer-reviewed clinical literature with primary qualitative interviews of clinicians, procurement professionals, and device engineers. Data was triangulated using supplier documentation, technical white papers, and observed clinical protocols to validate feature claims and identify emergent usage patterns. Analytical rigor was applied through cross-validation of device functionality, training requirements, and post-market support models, while attention to regional regulatory pathways informed assessments of adoption enablers and barriers.

Where possible, insights were corroborated through multiple independent sources and clinical end-user perspectives to ensure that assertions about device utility and operational fit reflect real-world workflows. Limitations of the methodology include variability in publicly disclosed performance data and the proprietary nature of some post-market outcomes, which were mitigated through targeted expert consultations. This mixed-methods approach yields actionable intelligence designed to inform strategic decisions without relying on proprietary market sizing or forecasting estimates.

Concluding synthesis emphasizing the necessity of integrated strategies that combine innovation, clinical alignment, and supply chain foresight to optimize transfusion practices

In conclusion, the blood transfusion device sector is maturing into a more sophisticated ecosystem where device automation, digital control, and supply chain strategy determine clinical and commercial success. Clinical imperatives such as leukocyte reduction, precise component separation, and safe transfusion delivery are driving differentiated product requirements and service expectations. Meanwhile, external pressures including tariff variability and regional regulatory diversity compel manufacturers and health systems to be more deliberate about sourcing, localization, and lifecycle support.

Moving forward, organizations that align product development with clinical workflows, invest in interoperable and sensor-driven technologies, and adopt resilient manufacturing and distribution strategies will be better positioned to meet both patient safety objectives and institutional procurement priorities. This conclusion underscores the importance of integrated strategies that combine technical innovation, operational foresight, and strong clinical collaborations to realize the full potential of modern transfusion device technology.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of pathogen reduction technologies improving blood safety in transfusion procedures
  • 5.2. Integration of smart sensors and IoT for real-time monitoring of blood unit quality during storage and transport
  • 5.3. Rising implementation of automated blood typing and antibody screening to reduce transfusion errors
  • 5.4. Development of portable blood warming and cooling systems for rapid transfusion support in emergency care
  • 5.5. Expansion of point-of-care blood analysis devices enabling immediate bedside compatibility testing
  • 5.6. Use of artificial intelligence algorithms to predict patient transfusion needs and optimize inventory management
  • 5.7. Growing demand for single-use sterile tubing and connectors to minimize contamination risks in transfusion sets
  • 5.8. Emergence of wearable continuous hemoglobin monitoring devices for non-invasive post-transfusion assessment

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Transfusion Devices Market, by Product

  • 8.1. Apheresis System
    • 8.1.1. Double Needle
    • 8.1.2. Single Needle
  • 8.2. Blood Bag
    • 8.2.1. Multi Pocket
    • 8.2.2. Single Pocket
  • 8.3. Blood Collection Set
    • 8.3.1. Closed System
    • 8.3.2. Open System
  • 8.4. Component Separator
    • 8.4.1. Automated Separator
    • 8.4.2. Manual Separator
  • 8.5. Leukocyte Reduction Filter
    • 8.5.1. Bedside
    • 8.5.2. Pre Storage
  • 8.6. Transfusion Pump
    • 8.6.1. Syringe
    • 8.6.2. Volumetric

9. Blood Transfusion Devices Market, by Application

  • 9.1. Apheresis
    • 9.1.1. Collection Apheresis
    • 9.1.2. Therapeutic Apheresis
  • 9.2. Blood Collection
    • 9.2.1. Apheresis Collection
    • 9.2.2. Whole Blood Collection
  • 9.3. Component Separation
    • 9.3.1. Centrifugation Based
    • 9.3.2. Filtration Based
  • 9.4. Leukocyte Reduction
    • 9.4.1. Centrifugation Based
    • 9.4.2. Filtration Based
  • 9.5. Transfusion
    • 9.5.1. Continuous Transfusion
    • 9.5.2. Intermittent Transfusion

10. Blood Transfusion Devices Market, by End User

  • 10.1. Blood Banks & Donation Centers
    • 10.1.1. Government Centers
    • 10.1.2. Private Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals

11. Blood Transfusion Devices Market, by Component

  • 11.1. Plasma
    • 11.1.1. Cryoprecipitate
    • 11.1.2. Fresh Frozen Plasma
  • 11.2. Platelets
    • 11.2.1. Apheresis Platelets
    • 11.2.2. Pooled Platelets
  • 11.3. Red Blood Cells
  • 11.4. White Blood Cells
    • 11.4.1. Granulocyte Concentrates
    • 11.4.2. Lymphocyte Concentrates

12. Blood Transfusion Devices Market, by Mode

  • 12.1. Automated
    • 12.1.1. Fully Automated Desktop
    • 12.1.2. Robotic Systems
  • 12.2. Manual
  • 12.3. Semi Automated
    • 12.3.1. Cartridge Based
    • 12.3.2. Cassette Based

13. Blood Transfusion Devices Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Hospital Pharmacies
    • 13.2.1. Centralized
    • 13.2.2. In House
  • 13.3. Online Sales
    • 13.3.1. B2B Platforms
    • 13.3.2. Manufacturer Websites
  • 13.4. Retail Pharmacies

14. Blood Transfusion Devices Market, by Technology

  • 14.1. Conventional Flow Control
    • 14.1.1. Gravity Fed
    • 14.1.2. Pressure Infusion
  • 14.2. Electronic Flow Control
    • 14.2.1. Microprocessor Based
    • 14.2.2. Sensor Based

15. Blood Transfusion Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Blood Transfusion Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Blood Transfusion Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Becton, Dickinson and Company
    • 18.3.2. Fresenius Kabi AG
    • 18.3.3. Terumo Corporation
    • 18.3.4. B. Braun Melsungen AG
    • 18.3.5. Haemonetics Corporation
    • 18.3.6. Baxter International Inc.
    • 18.3.7. Grifols, S.A.
    • 18.3.8. Macopharma SA
    • 18.3.9. Cerus Corporation
    • 18.3.10. Immucor, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. BLOOD TRANSFUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. BLOOD TRANSFUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BLOOD TRANSFUSION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, BY GROUP, 2018-2024